HLB Pep KRX:196300KOSDAQ

HLB펩 · Korean news coverage and regulatory filings, organized.

Articles, 24h31
Articles, 7 days32
DART filings, 7 days2
Articles tracked64since Sep 11

In Q3 2026, HLB Pep reported revenue of ₩1.3bn, up 11.0% year on year, and an operating loss of ₩1.1bn. HLB Pep (HLB펩) appeared in 32 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Nov 17 with 31 articles. The most common catalyst was clinical & approvals (12). It was most often mentioned alongside 글로벌테크놀로지.

Filing signals News surge Asset deal 4 quarters of losses Screener

HLB Pep today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 133 days · period ending Dec 2026

Dates HLB Pep stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

HLB Pep quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩1.3bn+11.0%−₩1.1bn
margin −81.9%
−₩318m
Q2 2026₩1.3bn+2.2%−₩1.4bn
margin −109.8%
−₩735m
Q1 2026₩1.6bn+50.9%−₩1.8bn
margin −111.5%
−₩3.0bn
Q4 2025 derived₩1.5bn+5.1%−₩3.2bn
margin −215.9%
₩2.6bn
Q3 2025₩1.2bn+5.2%−₩1.4bn
margin −119.3%
−₩2.1bn
Q2 2025₩1.2bn+1.6%−₩1.3bn
margin −102.5%
₩382m
Q1 2025₩1.1bn-56.5%−₩1.5bn
margin −136.6%
−₩1.6bn
Q4 2024 derived₩1.4bn+8.8%−₩1.3bn
margin −91.3%
−₩2.8bn

HLB Pep ranks #1996 of 2,596 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

HLB Pep top stories 2 weeks, by number of outlets

  1. 1
    HLB펩, 심임 사장으로 이원직 전 롯데바이오 대표 영입
    12 outlets · 13 articlesFirst report Nov 17 13:20 이뉴스투데이
  2. 2
    HLB Pep obtains Mexico approval for leuprorelin active pharmaceutical ingredient
    6 outlets · 6 articlesFirst report Nov 10 14:25 뉴스핌Regulatory approval
  3. 3
  4. 4
    Finished pharmaceutical using HLB Pep raw material receives Mexico approval
    5 outlets · 5 articlesFirst report Nov 10 14:28 파이낸셜뉴스Regulatory approval
  5. 5
    HLB펩 신임 사장에 이원직 전 롯데바이오 대표
    4 outlets · 4 articlesFirst report Nov 17 14:15 연합뉴스경제
  6. 6

Latest HLB Pep news Korean headlines